HUTCHMED (China) (HCM) EBIT Margin: 2014-2024
Historic EBIT Margin for HUTCHMED (China) (HCM) over the last 11 years, with Dec 2024 value amounting to -6.94%.
- HUTCHMED (China)'s EBIT Margin was N/A to -172.21% in Q4 2021 from the same period last year, while for Dec 2021 it was 33.17%, marking a year-over-year change of. This contributed to the annual value of -6.94% for FY2024, which is 1166.00% down from last year.
- Latest data reveals that HUTCHMED (China) reported EBIT Margin of -6.94% as of FY2024, which was down 246.68% from 4.73% recorded in FY2023.
- HUTCHMED (China)'s EBIT Margin's 5-year high stood at 4.73% during FY2023, with a 5-year trough of -133.25% in FY2022.
- For the 3-year period, HUTCHMED (China)'s EBIT Margin averaged around -45.15%, with its median value being -6.94% (2024).
- In the last 5 years, HUTCHMED (China)'s EBIT Margin plummeted by 4,106bps in 2022 and then soared by 13,798bps in 2023.
- Yearly analysis of 5 years shows HUTCHMED (China)'s EBIT Margin stood at -86.27% in 2020, then tumbled by 592bps to -92.19% in 2021, then tumbled by 4,106bps to -133.25% in 2022, then surged by 13,798bps to 4.73% in 2023, then slumped by 1,166bps to -6.94% in 2024.